Avacta Group Plc (LON:AVCT – Get Free Report) crossed above its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of GBX 59.90 ($0.76) and traded as high as GBX 70 ($0.89). Avacta Group shares last traded at GBX 67.50 ($0.86), with a volume of 417,553 shares trading hands.
Avacta Group Stock Performance
The firm has a market capitalization of £251.16 million, a price-to-earnings ratio of -783.33 and a beta of 1.16. The firm’s 50 day simple moving average is GBX 60.92 and its 200 day simple moving average is GBX 59.97. The company has a debt-to-equity ratio of 191.87, a quick ratio of 4.96 and a current ratio of 0.62.
About Avacta Group
Avacta Group Plc develops cancer therapies and diagnostics in the United Kingdom, France, North America, South Korea, and rest of Asia and Europe. The company operates through Diagnostics and Therapeutics segments. It develops products based on its proprietary Affimer and pre|CISION technology platforms.
Further Reading
- Five stocks we like better than Avacta Group
- What is a buyback in stocks? A comprehensive guide for investors
- Bumble’s Valuation Hits an All-Time Low, Can Its Fortunes Change?
- Best of the list of Dividend Aristocrats: Build wealth with the aristocrat index
- MarketBeat Week in Review – 8/12 – 8/16
- Find and Profitably Trade Stocks at 52-Week Lows
- JD.com Earnings Surprise: China’s Outlook Better Than Expected
Receive News & Ratings for Avacta Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avacta Group and related companies with MarketBeat.com's FREE daily email newsletter.
